Literature DB >> 17115060

Hematopoietic progenitor kinase 1 negatively regulates T cell receptor signaling and T cell-mediated immune responses.

Jr-Wen Shui1, Jonathan S Boomer, Jin Han, Jun Xu, Gregory A Dement, Guisheng Zhou, Tse-Hua Tan.   

Abstract

HPK1 is a Ste20-related serine-threonine kinase that inducibly associates with the adaptors SLP-76 and Gads after T cell receptor (TCR) signaling. Here, HPK1 deficiency resulted in enhanced TCR-induced phosphorylation of SLP-76, phospholipase C-gamma1 and the kinase Erk, more-persistent calcium flux, and increased production of cytokines and antigen-specific antibodies. Furthermore, HPK1-deficient mice were more susceptible to experimental autoimmune encephalomyelitis. Although the interaction between SLP-76 and Gads was unaffected, the inducible association of SLP-76 with 14-3-3tau (a phosphorylated serine-binding protein and negative regulator of TCR signaling) was reduced in HPK1-deficient T cells after TCR stimulation. HPK1 phosphorylated SLP-76 and induced the interaction of SLP-76 with 14-3-3tau. Our results indicate that HPK1 negatively regulates TCR signaling and T cell-mediated immune responses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17115060     DOI: 10.1038/ni1416

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  67 in total

Review 1.  Cbl-b in T-cell activation.

Authors:  Magdalena Paolino; Josef M Penninger
Journal:  Semin Immunopathol       Date:  2010-02-21       Impact factor: 9.623

Review 2.  Coordination of receptor signaling in multiple hematopoietic cell lineages by the adaptor protein SLP-76.

Authors:  Martha S Jordan; Gary A Koretzky
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-03-17       Impact factor: 10.005

3.  SH2 domain containing leukocyte phosphoprotein of 76-kDa (SLP-76) feedback regulation of ZAP-70 microclustering.

Authors:  Hebin Liu; Marco A Purbhoo; Daniel M Davis; Christopher E Rudd
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-13       Impact factor: 11.205

Review 4.  The LAT story: a tale of cooperativity, coordination, and choreography.

Authors:  Lakshmi Balagopalan; Nathan P Coussens; Eilon Sherman; Lawrence E Samelson; Connie L Sommers
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-07-07       Impact factor: 10.005

Review 5.  Targeting cancer with kinase inhibitors.

Authors:  Stefan Gross; Rami Rahal; Nicolas Stransky; Christoph Lengauer; Klaus P Hoeflich
Journal:  J Clin Invest       Date:  2015-05-01       Impact factor: 14.808

6.  Sequential phosphorylation of SLP-76 at tyrosine 173 is required for activation of T and mast cells.

Authors:  Meirav Sela; Yaron Bogin; Dvora Beach; Thomas Oellerich; Johanna Lehne; Jennifer E Smith-Garvin; Mariko Okumura; Elina Starosvetsky; Rachelle Kosoff; Evgeny Libman; Gary Koretzky; Taku Kambayashi; Henning Urlaub; Jürgen Wienands; Jonathan Chernoff; Deborah Yablonski
Journal:  EMBO J       Date:  2011-07-01       Impact factor: 11.598

Review 7.  HPK1 as a novel target for cancer immunotherapy.

Authors:  Sansana Sawasdikosol; Renyuan Zha; Boyu Yang; Steven Burakoff
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

8.  Proteasome-mediated degradation and functions of hematopoietic progenitor kinase 1 in pancreatic cancer.

Authors:  Hua Wang; Xianzhou Song; Craig Logsdon; Guisheng Zhou; Douglas B Evans; James L Abbruzzese; Stanley R Hamilton; Tse-Hua Tan; Huamin Wang
Journal:  Cancer Res       Date:  2009-01-13       Impact factor: 12.701

9.  Attenuation of T cell receptor signaling by serine phosphorylation-mediated lysine 30 ubiquitination of SLP-76 protein.

Authors:  Xiaohong Wang; Ju-Pi Li; Li-Li Chiu; Joung-Liang Lan; Der-Yuan Chen; Jonathan Boomer; Tse-Hua Tan
Journal:  J Biol Chem       Date:  2012-08-17       Impact factor: 5.157

10.  Hematopoietic progenitor kinase 1 is a critical component of prostaglandin E2-mediated suppression of the anti-tumor immune response.

Authors:  Saba Alzabin; Saiju Pyarajan; Herman Yee; Friedemann Kiefer; Akira Suzuki; Steven Burakoff; Sansana Sawasdikosol
Journal:  Cancer Immunol Immunother       Date:  2009-09-29       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.